Your browser doesn't support javascript.
loading
Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma.
Xu-Monette, Zijun Y; Wei, Li; Fang, Xiaosheng; Au, Qingyan; Nunns, Harry; Nagy, Máté; Tzankov, Alexandar; Zhu, Feng; Visco, Carlo; Bhagat, Govind; Dybkaer, Karen; Chiu, April; Tam, Wayne; Zu, Youli; Hsi, Eric D; Hagemeister, Fredrick B; Sun, Xiaoping; Han, Xin; Go, Heounjeong; Ponzoni, Maurilio; Ferreri, Andrés J M; Møller, Michael B; Parsons, Benjamin M; van Krieken, J Han; Piris, Miguel A; Winter, Jane N; Li, Yong; Xu, Bing; Albitar, Maher; You, Hua; Young, Ken H.
Afiliación
  • Xu-Monette ZY; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, North Carolina.
  • Wei L; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, North Carolina.
  • Fang X; Children's Hospital of Chongqing Medical University, Chongqing, China.
  • Au Q; Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
  • Nunns H; NeoGenomics Laboratories, Aliso Viejo, California.
  • Nagy M; NeoGenomics Laboratories, Aliso Viejo, California.
  • Tzankov A; NeoGenomics Laboratories, Aliso Viejo, California.
  • Zhu F; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
  • Visco C; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, North Carolina.
  • Bhagat G; University of Verona, Verona, Italy.
  • Dybkaer K; Columbia University Irving Medical Center and New York Presbyterian Hospital, New York, New York.
  • Chiu A; Aalborg University Hospital, Aalborg, Denmark.
  • Tam W; Mayo Clinic, Rochester, Minnesota.
  • Zu Y; Weill Medical College of Cornell University, New York, New York.
  • Hsi ED; The Methodist Hospital, Houston, Texas.
  • Hagemeister FB; Cleveland Clinic, Cleveland, Ohio.
  • Sun X; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Han X; Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Go H; Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ponzoni M; Asan Medical Center, Ulsan University College of Medicine, Seoul, Republic of South Korea.
  • Ferreri AJM; San Raffaele H. Scientific Institute, Milan, Italy.
  • Møller MB; San Raffaele H. Scientific Institute, Milan, Italy.
  • Parsons BM; Odense University Hospital, Odense, Denmark.
  • van Krieken JH; Gundersen Lutheran Health System, La Crosse, Wisconsin.
  • Piris MA; Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands.
  • Winter JN; Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • Li Y; Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
  • Xu B; Department of Medicine, Baylor College of Medicine, Houston, Texas.
  • Albitar M; The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China.
  • You H; Genomic Testing Cooperative, LCA, Irvine, California.
  • Young KH; Children's Hospital of Chongqing Medical University, Chongqing, China.
Clin Cancer Res ; 28(5): 972-983, 2022 Mar 01.
Article en En | MEDLINE | ID: mdl-34980601
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas c-myc / Linfoma de Células B Grandes Difuso / Proteína 1 Similar al Receptor de Interleucina-1 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas c-myc / Linfoma de Células B Grandes Difuso / Proteína 1 Similar al Receptor de Interleucina-1 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article